PVI
SRPT icon

Pura Vida Investments’s Sarepta Therapeutics SRPT Stock Holding History

Pura Vida Investments’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-40,000
Closed -$6.82M – 255
2020
Q4 		$6.82M Buy
+40,000
New +$5.93M 0.25% 85
2020
Q3 		– Sell
-132,400
Closed -$21.2M – 174
2020
Q2 		$21.2M Buy
132,400
+3,000
+2% +$408K 2.04% 14
2020
Q1 		$12.7M Buy
129,400
+20,400
+19% +$2.33M 1.5% 22
2019
Q4 		$14.1M Buy
109,000
+9,000
+9% +$908K 1.24% 24
2019
Q3 		$7.53M Buy
+100,000
New +$11.8M 1.29% 30
2016
Q2 		– Sell
-100,000
Closed -$1.95M – 88
2016
Q1 		$1.95M Buy
+100,000
New +$1.75M 0.89% 43

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pura Vida Investments's SRPT Position: Q2 2022 in Review

Pura Vida Investments sold out of Sarepta Therapeutics (SRPT) in Q2 2022, closing a stake of 25,850 shares — an estimated $1.9M sold.

Pura Vida Investments first reported a position in SRPT in Q3 2016 and held it in 5 quarters. The position peaked at $2.46M in Q3 2016. 332 funds tracked by Wall St. Rank hold SRPT as of Q2 2022.

  • Pura Vida Investments reported no remaining Sarepta Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Pura Vida Investments sold 25,850 Sarepta Therapeutics shares in Q2 2022, an estimated $1.9M.
  • Pura Vida Investments first reported a position in Sarepta Therapeutics in Q3 2016 and held it in 5 quarters.
  • Pura Vida Investments's Sarepta Therapeutics position peaked at $2.46M in Q3 2016.
  • 332 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2022.

Based on Pura Vida Investments's 13F filing for Q2 2022, filed 15 Aug 2022.